Recombinant Bacillus subtilis 6-phosphofructokinase (pfkA)

What is the structure and function of Bacillus subtilis 6-phosphofructokinase?

Bacillus subtilis 6-phosphofructokinase (PfkA) is an allosteric ATP-dependent enzyme that catalyzes a rate-limiting step in glycolysis. The enzyme belongs to the family of allosteric ATP-PFK enzymes and possesses conserved catalytic and regulatory residues. The pfk gene in B. subtilis shows high sequence identity with other bacterial species, including 68% identity with B. sphaericus PFK . The enzyme contains specific substrate-binding domains that interact with both ATP and fructose-6-phosphate (F-6-P).

The enzyme's active site includes critical residues involved in substrate binding. Ten out of eleven amino acids that constitute the substrate-binding domain in E. coli are conserved in related Bacillus species . Additionally, the ATP binding domain is highly conserved, with eight identical amino acids found across species. The gene organization surrounding pfk in B. subtilis follows the pattern accA-pfk-pykA, which is similar to that observed in other Bacillus species like B. halodurans .

What kinetic parameters characterize wild-type B. subtilis PfkA?

The kinetic parameters of B. subtilis PfkA reflect its role as a regulatory enzyme in glycolysis. While the search results don't provide specific values for B. subtilis PfkA, studies of related PFK enzymes show that their activity is absolutely dependent on both ATP and fructose-6-phosphate. In similar Bacillus species, the affinity constants (Km) for ATP and F-6-P were estimated to be approximately 0.11 mM and 0.29 mM, respectively .

When analyzing PFK enzymes, researchers typically measure several kinetic parameters:

Researchers conducting kinetic studies typically use coupled enzyme assays that monitor NADH oxidation at 340 nm to quantify PFK activity, with one unit of activity defined as the amount of enzyme needed to produce 1 μmol of fructose-1,6-bisphosphate per minute .

How is the pfkA gene typically cloned and expressed in recombinant systems?

Cloning and expression of the B. subtilis pfkA gene typically involves the following methodological steps:

• Gene identification and amplification: Design of specific primers based on the known pfkA sequence, followed by PCR amplification from B. subtilis genomic DNA.

• Vector construction: The amplified pfkA gene is inserted into an appropriate expression vector with a suitable promoter. Researchers often include affinity tags (His-tag or GST) to facilitate purification.

• Expression system selection: While E. coli is commonly used, expressing B. subtilis enzymes in B. subtilis itself can be advantageous for proper folding and post-translational modifications. Expression can be driven by constitutive promoters or inducible systems like IPTG-inducible promoters .

• Transformation and selection: The recombinant plasmid is introduced into the host strain through transformation, and successful transformants are selected using appropriate antibiotics.

• Expression verification: Expression is typically confirmed through SDS-PAGE, Western blotting, and enzyme activity assays. As demonstrated in similar studies, activity measurements confirm that the expressed enzyme requires both ATP and F-6-P for activity .

• Functional complementation: A powerful approach to verify the functionality of recombinant PfkA is to express it in a strain lacking endogenous PFK activity. For example, in studies with related pfk genes, expression in E. coli DF1020 (which lacks PFK activity) restored the cell's ability to grow on specific carbon sources like mannitol .

What site-directed mutagenesis approaches are effective for studying the structure-function relationship of B. subtilis PfkA?

Site-directed mutagenesis represents a powerful approach for investigating the structural and functional properties of B. subtilis PfkA. Based on insights from related PFK enzymes, researchers should focus on the following methodological considerations:

• Target residue selection: Key residues for mutagenesis include those involved in substrate binding, allosteric regulation, and subunit interactions. For instance, studies on related PFK enzymes highlight the importance of Arg-162, which when mutated to alanine (R162A) causes an approximately 30-fold increase in the K1/2 for fructose-6-phosphate .

• Mutagenesis strategy:

  • Use PCR-based approaches with mutagenic primers containing the desired nucleotide changes

  • Employ overlap extension PCR to introduce mutations in the middle of sequences

  • Consider creating single mutants, double mutants, and mutation series to fully characterize functional domains

• Functional characterization:

  • Compare the kinetic parameters (Km, kcat, K1/2) of mutant enzymes with wild-type

  • Examine changes in allosteric regulation by effectors like PEP

  • Assess cooperativity changes through Hill coefficient analysis

  • Use fluorescence techniques to monitor conformational changes

• Data analysis framework: When analyzing mutagenesis data, researchers should:

  • Determine the coupling free energy (ΔGay) between substrates and allosteric effectors

  • Calculate the coupling constant (Qay) to quantify the allosteric effect

  • Apply appropriate thermodynamic models to interpret changes in enzyme behavior

  • Consider the rapid-equilibrium assumption when analyzing steady-state kinetics

A comprehensive mutational analysis should include both conservative and non-conservative substitutions. For example, when studying the role of charged residues like Glu-161 and Arg-162, researchers might create mutations that neutralize charge (E161A, R162A), reverse charge (E161K, R162E), or maintain charge while altering size (E161D, R162K) .

How can allosteric regulation of B. subtilis PfkA be characterized experimentally?

Characterizing the allosteric regulation of B. subtilis PfkA requires a multi-faceted experimental approach:

• Kinetic analysis in the presence of allosteric effectors:

  • Perform steady-state kinetic assays with varying concentrations of both substrate (F-6-P) and allosteric effectors

  • Construct substrate saturation curves at different effector concentrations

  • Determine K1/2 values as a function of effector concentration

  • Calculate the coupling constant (Qay) that quantifies the allosteric effect

• Steady-state fluorescence techniques:

  • Measure changes in intrinsic tryptophan fluorescence upon ligand binding

  • Use excitation at 300 nm and detect emission through appropriate filters (e.g., WG 335-nm cut-on filter)

  • Titrate the enzyme with substrate or effector and monitor emission intensity changes

  • Correct all measurements for blank contributions and dilution effects

• Structural analysis methods:

  • X-ray crystallography of the enzyme in different states (apo, substrate-bound, effector-bound)

  • Explore conformational changes that occur upon binding of allosteric effectors

  • Focus on key residues and domains that undergo significant movement

• Thermodynamic linkage analysis:

  • Determine binding constants for substrate in the absence and presence of effectors

  • Calculate the coupling free energy (ΔGay) between substrate and effector binding

  • Analyze the reciprocity of effects between substrate and effector sites

For example, studies on the related Bacillus stearothermophilus PFK have revealed that PEP acts as an allosteric inhibitor by diminishing the affinity for F-6-P. This involves a conformational change where residues Glu-161 and Arg-162 undergo substantial movement depending on whether substrate or inhibitor is bound . When F-6-P is bound, Arg-162 protrudes into the active site to interact with the phosphate group of F-6-P. Conversely, when an inhibitor like phosphoglycolate binds to the allosteric site, Arg-162 moves away from the active site and is replaced by the negatively charged Glu-161, introducing electrostatic repulsion with incoming F-6-P molecules .

What expression systems optimize yield and activity of recombinant B. subtilis PfkA?

Optimizing the expression of recombinant B. subtilis PfkA requires careful consideration of expression hosts, vectors, and conditions:

• Host selection considerations:

  • E. coli systems: Provide high yields but may present folding challenges for Bacillus proteins

  • B. subtilis systems: Offer native cellular environment but typically lower yields

  • Cell-free systems: Allow precise control of reaction conditions but at higher cost

• Vector design strategies:

  • Promoter selection (constitutive vs. inducible)

  • Codon optimization for the host organism

  • Inclusion of appropriate secretion signals if extracellular production is desired

  • Fusion partners that may enhance solubility (GST, MBP, SUMO)

  • Affinity tags for purification (His-tag, Strep-tag)

• Expression conditions optimization:

  Parameter	Variables to Test	Monitoring Method
  Induction timing	OD600 at induction	Growth curves
  Inducer concentration	IPTG (0.1-1.0 mM)	SDS-PAGE, activity assays
  Temperature	16-37°C	Solubility analysis
  Media composition	LB, TB, minimal media	Yield comparison
  Harvest timing	4-24h post-induction	Time-course sampling

• Purification strategy:

  • Initial capture using affinity chromatography

  • Further purification via ion exchange or size exclusion chromatography

  • Activity measurements at each purification step

  • Stability assessment during storage

Research with related proteins has demonstrated the effectiveness of expression systems utilizing IPTG-inducible promoters. For example, studies have successfully used the pQE30 vector with BamHI-HindIII restriction sites for expression in E. coli . Activity assays showed that E. coli cells carrying the recombinant PFK gene exhibited significant enzyme activity (27 nmol min⁻¹ mg protein⁻¹) compared to control cells (<1 nmol min⁻¹ mg protein⁻¹) .

How can recombinant B. subtilis PfkA be used to investigate metabolic regulation in bacteria?

Recombinant B. subtilis PfkA serves as a powerful tool for investigating metabolic regulation in bacteria through several experimental approaches:

• Metabolic flux analysis:

  • Express wild-type or mutant PfkA variants in PFK-deficient strains

  • Measure glycolytic flux using isotope-labeled glucose

  • Quantify changes in the distribution of metabolic intermediates

  • Correlate enzyme kinetic parameters with in vivo flux data

• Systems biology applications:

  • Integrate PfkA activity data into genome-scale metabolic models

  • Predict the effects of PfkA mutations on cellular metabolism

  • Validate model predictions through experimental measurement of growth rates and metabolite levels

  • Identify emergent properties of glycolytic regulation

• Comparative studies across species:

  • Express PfkA orthologs from different bacterial species in a common host

  • Compare kinetic parameters, allosteric regulation, and temperature dependence

  • Analyze the correlation between PfkA properties and the ecological niche of the source organism

  • Identify conserved regulatory mechanisms versus species-specific adaptations

• Investigation of protein-protein interactions:

  • Use recombinant PfkA as bait in pull-down or two-hybrid experiments

  • Identify potential interaction partners in the glycolytic pathway

  • Characterize the functional consequences of these interactions

  • Study the formation of metabolic enzyme complexes or "metabolons"

Gene organization studies indicate that in B. subtilis, the pfk gene is positioned between accA (encoding acetyl coenzyme A carboxylase carboxyltransferase alpha subunit) and pykA (encoding pyruvate kinase) . This genomic organization suggests potential co-regulation of these enzymes, which participate in different but related metabolic pathways. Additionally, research indicates that PykA interacts with other proteins like DnaE polymerase in B. subtilis, suggesting complex regulatory networks involving glycolytic enzymes .

What approaches resolve contradictory data on B. subtilis PfkA allosteric regulation?

When faced with contradictory data regarding the allosteric regulation of B. subtilis PfkA, researchers should implement the following methodological approaches:

• Standardization of experimental conditions:

  • Establish consistent buffer compositions, pH, temperature, and ionic strength

  • Define standard enzyme preparation protocols to ensure uniform protein quality

  • Use multiple batches of independently purified enzyme to assess reproducibility

  • Validate results across different laboratories with standardized protocols

• Comprehensive characterization of allosteric effectors:

  • Test a wide range of potential effectors at physiologically relevant concentrations

  • Generate complete dose-response curves rather than single-point measurements

  • Investigate combinations of effectors to detect synergistic or antagonistic effects

  • Consider the influence of divalent cations (Mg²⁺, Mn²⁺) on effector binding

• Mutational analysis to resolve mechanistic discrepancies:

  • Create site-directed mutations in putative allosteric sites

  • Measure the effect of mutations on both substrate binding and effector response

  • Use double-mutant cycles to probe energetic coupling between residues

  • Compare results with predictions from different mechanistic models

• Integration of structural and functional data:

  • Combine X-ray crystallography, cryo-EM, or NMR with functional assays

  • Perform molecular dynamics simulations to explore conformational changes

  • Use hydrogen-deuterium exchange mass spectrometry to probe protein dynamics

  • Apply FRET techniques to monitor real-time conformational changes

Further mutational studies demonstrated that while R162A mutation decreased the enzyme's affinity for F-6-P by 30-fold, it reduced PEP inhibition by only one-third, challenging the simple electrostatic repulsion model . This highlights the importance of rigorous thermodynamic characterization and the integration of multiple experimental approaches to resolve contradictory findings.

How does temperature affect the structure and activity of recombinant B. subtilis PfkA?

Understanding the temperature dependence of B. subtilis PfkA structure and activity requires systematic investigation across several dimensions:

• Kinetic parameter determination across a temperature range:

  • Measure enzyme activity at temperatures from 10-70°C

  • Determine the temperature optimum for catalytic activity

  • Calculate activation energy (Ea) from Arrhenius plots

  • Analyze changes in Km, kcat, and allosteric parameters as a function of temperature

• Structural stability assessment:

  • Use differential scanning calorimetry (DSC) to determine melting temperature (Tm)

  • Monitor thermal unfolding through circular dichroism (CD) spectroscopy

  • Assess aggregation propensity at elevated temperatures

  • Measure activity recovery after thermal stress to evaluate reversibility

• Molecular basis of thermal adaptation:

  • Compare PfkA from B. subtilis (mesophilic) with orthologs from thermophilic (B. stearothermophilus) and psychrophilic bacteria

  • Identify sequence and structural features that correlate with thermal stability

  • Create chimeric enzymes to map regions responsible for temperature adaptation

  • Design mutations that alter thermal stability without compromising activity

• Advanced biophysical characterization:

  Method	Information Provided	Temperature Range
  Hydrogen-deuterium exchange MS	Conformational flexibility	5-40°C
  X-ray crystallography	Atomic resolution structure	Crystal growth temperature
  Small-angle X-ray scattering	Solution structure, oligomerization	10-60°C
  NMR spectroscopy	Dynamics, local unfolding	5-50°C

Studies on related PFK enzymes from different Bacillus species have revealed important insights about temperature adaptation. B. stearothermophilus, a thermophilic organism, possesses a PFK with high thermal stability, while maintaining similar catalytic and regulatory properties to mesophilic PFKs . The mechanistic basis for this thermal adaptation involves subtle differences in amino acid composition, particularly in regions not directly involved in catalysis or regulation.

Researchers studying temperature effects should consider that allosteric regulation can be temperature-dependent, with coupling constants (Qay) potentially varying with temperature. This can lead to shifts in the metabolic control architecture at different growth temperatures, an important consideration when studying B. subtilis adaptation to environmental conditions.

What are common pitfalls in purifying active recombinant B. subtilis PfkA and how can they be addressed?

Purifying active recombinant B. subtilis PfkA presents several challenges that researchers commonly encounter. Here are the major pitfalls and their solutions:

• Protein solubility issues:

  • Problem: Formation of inclusion bodies during overexpression

  • Solutions:

    • Lower the expression temperature to 16-20°C

    • Reduce inducer concentration

    • Co-express with molecular chaperones (GroEL/ES, DnaK/J)

    • Use solubility-enhancing fusion partners (MBP, SUMO, Trx)

    • Express as a secreted protein using appropriate signal sequences

• Loss of activity during purification:

  • Problem: Enzyme inactivation during extraction or chromatography steps

  • Solutions:

    • Include glycerol (10-20%) in all buffers to stabilize the enzyme

    • Add reducing agents (DTT, β-mercaptoethanol) to prevent oxidation

    • Maintain low temperature (4°C) throughout purification

    • Include substrate analogs or stabilizing ligands in purification buffers

    • Minimize exposure to air/oxygen during processing

• Cofactor requirements for stability and activity:

  • Problem: Loss of essential metal ions or cofactors during purification

  • Solutions:

    • Include Mg²⁺ (1-5 mM) in all buffers as it's essential for PFK activity

    • Avoid strong chelating agents like EDTA

    • Consider dialysis against buffers containing low concentrations of substrates

    • Test activity with various divalent cations to identify optimal conditions

• Heterogeneity in oligomeric state:

  • Problem: Variable quaternary structure affecting activity measurements

  • Solutions:

    • Use size exclusion chromatography to separate different oligomeric forms

    • Analyze oligomeric state by native PAGE or analytical ultracentrifugation

    • Include stabilizing agents that promote the active quaternary structure

    • Consider crosslinking strategies to maintain the functional oligomeric state

• Purification troubleshooting guide:

  Issue	Diagnostic Indicators	Corrective Actions
  Low yield	Weak band on SDS-PAGE	Optimize expression, improve extraction
  Proteolysis	Multiple bands below expected MW	Add protease inhibitors, reduce purification time
  Aggregation	Protein in void volume of SEC	Screen buffer conditions, add stabilizing agents
  Inactive enzyme	Low activity despite high protein concentration	Check for cofactors, verify proper folding
  Contaminants	Additional bands on SDS-PAGE	Introduce additional purification steps

When working with recombinant PFK enzymes, researchers have found that activity is absolutely dependent on the presence of both ATP and F-6-P in the reaction mixture . Therefore, activity assays should always include proper controls to verify that commercial enzymes and reagents used in the assays are not contaminated with ATP-PFK activity, which could lead to false positive results .

How can researchers accurately measure and interpret allosteric effects in B. subtilis PfkA?

Accurate measurement and interpretation of allosteric effects in B. subtilis PfkA require rigorous experimental approaches and analytical frameworks:

• Experimental design considerations:

  • Steady-state kinetic approaches:

    • Conduct substrate titrations at multiple fixed concentrations of allosteric effectors

    • Ensure measurements are taken at initial velocity conditions (<10% substrate consumption)

    • Include enough data points in the transition region between low and high substrate affinity states

    • Verify that the enzyme concentration is significantly below substrate Km to maintain steady-state conditions

  • Binding studies:

    • Use techniques like isothermal titration calorimetry (ITC) to directly measure binding affinities

    • Employ fluorescence-based methods to monitor conformational changes upon effector binding

    • Perform equilibrium dialysis to determine binding constants in complex situations

    • Control temperature precisely as allosteric coupling is temperature-dependent

• Data analysis framework:

  • Apply appropriate allosteric models:

    • Monod-Wyman-Changeux (MWC) model for concerted transitions

    • Koshland-Némethy-Filmer (KNF) model for sequential transitions

    • Linked-function analysis for thermodynamic characterization

  • Calculate key allosteric parameters:

    • Coupling constant (Qay) that quantifies the reciprocal effect between substrate and effector

    • Coupling free energy (ΔGay) that provides the thermodynamic basis for allostery

    • Hill coefficient (nH) as a measure of cooperativity

• Validation approaches:

  • Construct thermodynamic cycles to verify consistency of measurements

  • Test predictions of allosteric models through site-directed mutagenesis

  • Compare results from multiple experimental techniques

  • Examine the temperature and pH dependence of allosteric coupling

• Common pitfalls and solutions:

  Pitfall	Manifestation	Solution
  Enzyme heterogeneity	Non-hyperbolic kinetics	Ensure homogeneous enzyme preparation
  Substrate depletion	Non-linear progress curves	Use coupled assays, lower enzyme concentration
  Overlooking rapid equilibrium	Misinterpretation of kinetic data	Verify rapid equilibrium assumption experimentally
  Ignoring reciprocity	Incomplete mechanistic models	Measure effects in both directions

Research on related PFK enzymes has demonstrated the importance of applying rigorous thermodynamic analyses. For example, studies on B. stearothermophilus PFK showed that PEP inhibition involves more than simple competitive binding . The rapid-equilibrium assumption was validated for this enzyme, allowing the extraction of the coupling constant (Qay) from steady-state kinetic data . This parameter quantifies the maximum extent to which an allosteric effector can change the enzyme's affinity for its substrate.

What computational methods are most effective for predicting interactions between B. subtilis PfkA and potential allosteric modulators?

Computational methods provide powerful tools for predicting interactions between B. subtilis PfkA and potential allosteric modulators. The following approaches have proven effective:

• Structure-based methods:

  • Molecular docking:

    • Use algorithms like AutoDock, Glide, or DOCK to screen virtual compound libraries

    • Employ ensemble docking with multiple protein conformations to account for flexibility

    • Validate docking scores against known modulators before predicting novel interactions

    • Incorporate water molecules in binding site for more accurate predictions

  • Molecular dynamics simulations:

    • Perform long-timescale (>100 ns) simulations to capture conformational changes

    • Analyze allosteric communication pathways using methods like dynamic network analysis

    • Apply enhanced sampling techniques (metadynamics, accelerated MD) to study rare events

    • Calculate binding free energies using methods like MM/PBSA or thermodynamic integration

• Sequence-based approaches:

  • Conduct evolutionary coupling analysis to identify co-evolving residues

  • Use statistical coupling analysis to map allosteric networks

  • Perform multiple sequence alignments across PFK family to identify conserved regulatory sites

  • Apply machine learning methods trained on known allosteric enzymes to predict regulatory hotspots

• Integration of experimental and computational data:

  • Guide computational studies with experimental mutagenesis data

  • Validate computational predictions through targeted experiments

  • Use NMR chemical shift data to refine computational models

  • Apply hydrogen-deuterium exchange mass spectrometry data to identify dynamic regions

• Workflow for computational prediction of allosteric modulators:

  Stage	Methods	Expected Outcomes
  Initial screening	Virtual screening, pharmacophore modeling	Candidate compounds (100-1000)
  Refinement	Molecular dynamics, binding free energy calculations	Prioritized compounds (10-50)
  Specificity analysis	Off-target prediction, selectivity modeling	Lead compounds (3-10)
  Mechanism prediction	Pathway analysis, community network models	Allosteric mechanism hypotheses

How do protein-protein interactions influence B. subtilis PfkA activity in the cellular context?

Understanding the protein-protein interactions that influence B. subtilis PfkA activity in the cellular context represents an emerging area of research with significant implications for metabolic regulation:

• Identifying interaction partners:

  • Proteomic approaches:

    • Affinity purification coupled with mass spectrometry (AP-MS)

    • Proximity-dependent biotin identification (BioID) or APEX labeling

    • Crosslinking mass spectrometry (XL-MS) to capture transient interactions

    • Two-hybrid screens (bacterial or yeast systems) with PfkA as bait

  • Functional genomic approaches:

    • Synthetic genetic array (SGA) analysis to identify genetic interactions

    • Global protein localization studies to identify co-localized proteins

    • Transcriptional co-regulation analysis to identify functionally related proteins

    • Metabolic flux analysis in strains with altered expression of potential interactors

• Characterizing interaction mechanisms:

  • Determine binding interfaces using mutagenesis and structural biology

  • Analyze the kinetic effects of interacting partners on PfkA activity

  • Investigate how interactions are regulated by metabolites or post-translational modifications

  • Explore how interactions change under different growth conditions or stresses

• Metabolic enzyme complexes:

  • Investigate the formation of glycolytic enzyme complexes or "metabolons"

  • Study the role of PfkA in organizing higher-order metabolic structures

  • Analyze how enzyme clustering affects substrate channeling and reaction efficiency

  • Develop methods to visualize these complexes in living cells

The gene organization in B. subtilis places pfk adjacent to genes encoding other metabolic enzymes, including pyruvate kinase (pykA) , suggesting potential functional relationships. Recent research has demonstrated that PykA in B. subtilis interacts with proteins outside the glycolytic pathway, such as the replicative polymerase DnaE, modulating its activity when bound to DNA templates . This finding opens the possibility that PfkA may similarly engage in unexpected protein-protein interactions that connect metabolism with other cellular processes.

The heterotrophic effectors of PykA in B. subtilis are AMP and ribose 5-phosphate , raising questions about whether these or related metabolites might also mediate interactions between PfkA and its protein partners. Understanding these interaction networks will provide insights into how glycolytic activity is coordinated with other aspects of bacterial physiology.

What novel approaches can differentiate the roles of B. subtilis PfkA isoforms in different metabolic contexts?

Differentiating the roles of B. subtilis PfkA isoforms in various metabolic contexts requires innovative experimental approaches:

• Isoform-specific characterization strategies:

  • Genetic approaches:

    • Generate strains expressing only specific isoforms through targeted gene replacements

    • Create fluorescently tagged isoforms to monitor subcellular localization

    • Employ CRISPR interference to selectively downregulate specific isoforms

    • Develop promoter swapping strategies to alter isoform expression patterns

  • Biochemical approaches:

    • Develop isoform-specific antibodies for immunoprecipitation and localization studies

    • Design activity assays that can distinguish between isoform contributions

    • Characterize kinetic parameters and allosteric regulation of purified isoforms

    • Analyze post-translational modifications unique to each isoform

• Metabolic context analysis:

  • Nutrient-responsive expression:

    • Profile isoform expression across different carbon sources

    • Analyze promoter activity using reporter fusions under various conditions

    • Determine how nutrient shifts trigger changes in isoform ratios

    • Map the transcriptional regulatory networks controlling each isoform

  • Stress response roles:

    • Investigate isoform expression during oxidative, osmotic, or temperature stress

    • Determine stress resistance phenotypes of isoform-specific mutants

    • Analyze metabolic flux distributions during stress adaptation

    • Explore connections between isoform activity and stress signaling pathways

• Systems biology integration:

  • Develop mathematical models incorporating isoform-specific parameters

  • Perform flux balance analysis with constraints based on isoform properties

  • Integrate transcriptomic, proteomic, and metabolomic data to contextualize isoform roles

  • Use comparative genomics to identify conservation patterns of isoforms across Bacillus species

• Advanced analytical methods:

  Technique	Application to Isoform Analysis	Expected Insights
  Parallel reaction monitoring MS	Quantify isoform-specific peptides	Absolute quantification of isoform ratios
  SILAC proteomics	Measure isoform turnover rates	Differential stability and regulation
  Metabolic flux analysis	Map carbon flow in isoform mutants	Metabolic consequences of isoform differences
  Single-cell microscopy	Visualize isoform localization	Spatial organization and heterogeneity

While specific information about B. subtilis PfkA isoforms is limited in the provided search results, studies in related organisms have shown that PFK can exist in multiple forms with distinct regulatory properties. Research approaches should consider that isoforms may arise from different genes, alternative splicing (in eukaryotes), or post-translational modifications that alter enzyme function.

How can engineered variants of B. subtilis PfkA contribute to synthetic metabolic pathways?

Engineered variants of B. subtilis PfkA offer significant potential for synthetic metabolic pathways and biotechnological applications:

• Rational enzyme engineering approaches:

  • Altering substrate specificity:

    • Modify the substrate-binding pocket to accept non-natural sugar phosphates

    • Engineer PfkA variants that can utilize alternative phosphoryl donors beyond ATP

    • Create enzymes with reduced product inhibition for improved pathway flux

    • Design variants with optimal activity under industrial process conditions

  • Modifying regulatory properties:

    • Remove allosteric inhibition by mutating regulatory sites

    • Engineer novel allosteric responses to desired regulatory molecules

    • Create constitutively active variants insensitive to cellular metabolite fluctuations

    • Develop PfkA variants with altered temperature or pH optima

• Applications in metabolic engineering:

  • Enhance carbon flux through glycolysis by overcoming rate-limiting steps

  • Redirect metabolic flux toward valuable products by altering enzyme regulation

  • Enable utilization of non-conventional carbon sources through substrate specificity engineering

  • Improve metabolic efficiency by reducing ATP consumption or enhancing thermodynamic driving force

• Integration into synthetic pathways:

  • Design synthetic protein scaffolds that co-localize PfkA with other pathway enzymes

  • Create fusion proteins linking PfkA to enzymes with complementary functions

  • Develop synthetic regulatory circuits that control PfkA activity in response to desired inputs

  • Incorporate engineered PfkA variants into minimal cell designs or cell-free systems

• Experimental validation strategies:

  Approach	Metrics	Methods
  In vitro pathway reconstruction	Pathway flux, intermediate accumulation	Coupled enzyme assays, HPLC analysis
  Whole-cell biocatalysis	Product yield, substrate consumption rate	Fermentation analysis, metabolite quantification
  Computational pathway prediction	Thermodynamic feasibility, flux balance	Genome-scale metabolic modeling
  Evolution-guided optimization	Fitness improvement, adaptation rate	Continuous culture, adaptive laboratory evolution

Research with related enzymes has demonstrated the feasibility of protein engineering approaches. For example, B. subtilis can be used as an expression system for recombinant proteins, as shown by successful expression of glutathione-S-transferase (GST) fusion proteins . This suggests that engineered PfkA variants could similarly be expressed and utilized in B. subtilis systems.

Furthermore, understanding the structural basis of allosteric regulation, such as the conformational changes involving residues like Glu-161 and Arg-162 in related PFK enzymes , provides a foundation for rational design of PfkA variants with altered regulatory properties. These engineered enzymes could serve as key components in synthetic metabolic pathways designed for bioproduction of valuable compounds or bioremediation applications.